ADERANS RESEARCH Launches Second Phase of Hair Loss Study
http://www.prweb.com/releases/pattern_h ... 358404.htm
27 Apr 2009
Aderans Research Institute Inc. (ARI) announced today it has launched Phase 2 of its clinical study on cell-based hair regeneration for men and women. Structured around the findings of the recently completed Phase 1 of the study, this second phase will continue to evaluate the impact of its novel cell treatment process on pattern hair loss, also known as androgenetic alopecia.
Phase 2 of the study is being conducted in six U.S. cities: Atlanta, Boston, New York, Raleigh, Houston, and Washington DC. Phase 1 was conducted exclusively in the United Kingdom.
"The second phase of this study is another step in our efforts to truly understand the impact of regenerative cell therapy on pattern hair loss. It's a tremendous opportunity," says Kurt Stenn, MD, Vice President and Chief Scientific Officer. The company's research is focused on developing a state-of-the-art tissue engineering solution to the regeneration of hair, taking actual hair cells--fibroblasts and keratinocytes, the two primary cell types within hair follicles--and promoting their growth in controlled laboratory environments. The research teams then recombine them and these "combined hair cells" are then placed in the patient's skin, where they are expected to elicit hair growth. "This is research the industry has always wanted to do, and ARI has combined the support, the market, and the scientific wherewithal to do it," says Vern Liebmann, Vice President, Operations.
More information on study outcomes will be released as our studies conclude. To see ARI's latest clinical updates, please visit
http://www.aderansresearch.com/ari_clinicupdates.html
With offices in Atlanta and Philadelphia, the Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world's largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.
Additional information on ARI can be found at http://www.aderansresearch.com
ADERANS RESEARCH Launches Second Phase of Hair Loss Study - 27 Apr 2009
Moderator: moderators
-
- Prolific Poster
- Posts: 3525
- Joined: Fri Dec 12, 2003 9:38 am
- Hair Loss Type: Don't Know
- Have you had a hair transplant?: No
Re: ADERANS RESEARCH Launches Second Phase of Hair Loss Study - 27 Apr 2009
Looks good. A lot of ppl see "Bosley" and get scared off though.
-
- Prolific Poster
- Posts: 203
- Joined: Thu Feb 26, 2009 9:36 am
- Hair Loss Type: Androgenetic Alopecia (Male Pattern Baldness)
- Norwood Level: Norwood II A
- Have you had a hair transplant?: No
Re: ADERANS RESEARCH Launches Second Phase of Hair Loss Study - 27 Apr 2009
Thanks for the info!
- HairLossFight.com
- Site Admin
- Posts: 1218
- Joined: Sun Aug 24, 2003 3:24 am
- Hair Loss Type: Androgenetic Alopecia (Male Pattern Baldness)
- Norwood Level: Norwood III Vertex
- Have you had a hair transplant?: Yes
Re: ADERANS RESEARCH Launches Second Phase of Hair Loss Study - 27 Apr 2009
Good to see they're making progress. Thanks for the update Chrome!
-
- Seasoned Poster
- Posts: 59
- Joined: Tue Feb 09, 2010 3:44 pm
- Hair Loss Type: Other
- Norwood Level: Norwood V
- Have you had a hair transplant?: No
- Treatment Regimen: Nizoral 2% 2x/week started on May-2011.
Finasteride 1.25g 6x/week started Oct-2011.
Minoxidil 5% 7x/week started on Nov-2011.
Re: ADERANS RESEARCH Launches Second Phase of Hair Loss Study - 27 Apr 2009
ARI Releases Results of First Protocol
With this regard I think Histogen is closer with concrete results and pictures. (In my opinion, impressive) news dated April 13, 2010 here
No numbers... very vague.Atlanta, GA (PRWEB) December 15, 2010 -- Aderans Research Institute (ARI) recently completed the first of
seven protocols of a hair regeneration Phase 2 clinical study, and the results are in: more than half of study
participants showed significant hair growth one year after the cell product treatment was administered.
“The results indicate that our scientific approach, our research and understanding of follicular cell and hair
regeneration is headed in the right direction,” said Vern Liebmann, Vice President Operations. “The fact that an
increase in hair growth is apparent as far out as one year after treatment indicates our process has staying
power. Nobody we know of has produced results like these.”
...
Two new protocols are scheduled to begin this month, and based on the results to date, they are expected to
produce even greater benefits with continued durability of response of observed hair growth.
...
With this regard I think Histogen is closer with concrete results and pictures. (In my opinion, impressive) news dated April 13, 2010 here
Who is online
Users browsing this forum: No registered users and 18 guests